Last Frontier Eye Care - Medicare Optometrist in Nome, AK

Last Frontier Eye Care is a medicare enrolled "Optometrist" provider in Nome, Alaska. Their current practice location is 309 Bering St, Nome, Alaska. You can reach out to their office (for appointments etc.) via phone at (907) 443-3553.

Last Frontier Eye Care is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Last Frontier Eye Care is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1811598535.

Contact Information

Last Frontier Eye Care
309 Bering St,
Nome, AK 99762
(907) 443-3553
(844) 901-4313



Healthcare Provider's Profile

Full NameLast Frontier Eye Care
TypeFacility
SpecialityOptometrist
Location309 Bering St, Nome, Alaska
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1811598535
  • Provider Enumeration Date: 11/09/2020
  • Last Update Date: 02/23/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 1850702325
  • Enrollment ID: O20210405002216

Medical Identifiers

Medical identifiers for Last Frontier Eye Care such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1811598535NPI-NPPES
1070705MedicaidAK

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Last Frontier Eye Care acts as a billing entity for following providers:
Provider NameKamey K Kapp
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1013172584
PECOS PAC ID: 8527197474
Enrollment ID: I20100602000500

News Archive

ImpactRx launches smart-phone application for physicians

ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.

Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC

Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.

Researchers reveal how cancer cells succeed at entrapping genetic program of growth inhibition

Healthy cells reduce their growth when there is a lack of oxygen (hypoxia). This makes it even more surprising that hypoxia is a characteristic feature of malignant tumours. In two publications in the current edition of the "Nature Communications" journal, researchers from Goethe University and Justus-Liebig-University of Giessen report on how cancer cells succeed at circumventing the genetic program of growth inhibition.

Transplantation of B10 cells helps inhibit development of bladder fibrosis post SCI

A team of researchers from Korea and Canada have found that transplantation of B10 cells (a stable immortalized human bone marrow derived -mesenchymal stem cell line; B10 hMSC) directly into the bladder wall of mice modeled with spinal cord injury (SCI) helped inhibit the development of bladder fibrosis and improved bladder function by promoting the growth of smooth muscle cells in the bladder.

Stony Brook Burn Center doctor offers tips on preventing burn injuries during the holiday season

It's the 'most wonderful time of the year' - but it is also one of the busiest times of year for the Suffolk County Volunteer Firefighters Burn Center at Stony Brook University Hospital. As the holidays approach, doctors at the Burn Center are urging people to take extra precautions and to eliminate potential dangers that could lead to serious burn injuries.

Read more Medical News

› Verified 4 days ago

Provider NameMarcy O'neil
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1881905172
PECOS PAC ID: 4981893153
Enrollment ID: I20110104001268

News Archive

ImpactRx launches smart-phone application for physicians

ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.

Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC

Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.

Researchers reveal how cancer cells succeed at entrapping genetic program of growth inhibition

Healthy cells reduce their growth when there is a lack of oxygen (hypoxia). This makes it even more surprising that hypoxia is a characteristic feature of malignant tumours. In two publications in the current edition of the "Nature Communications" journal, researchers from Goethe University and Justus-Liebig-University of Giessen report on how cancer cells succeed at circumventing the genetic program of growth inhibition.

Transplantation of B10 cells helps inhibit development of bladder fibrosis post SCI

A team of researchers from Korea and Canada have found that transplantation of B10 cells (a stable immortalized human bone marrow derived -mesenchymal stem cell line; B10 hMSC) directly into the bladder wall of mice modeled with spinal cord injury (SCI) helped inhibit the development of bladder fibrosis and improved bladder function by promoting the growth of smooth muscle cells in the bladder.

Stony Brook Burn Center doctor offers tips on preventing burn injuries during the holiday season

It's the 'most wonderful time of the year' - but it is also one of the busiest times of year for the Suffolk County Volunteer Firefighters Burn Center at Stony Brook University Hospital. As the holidays approach, doctors at the Burn Center are urging people to take extra precautions and to eliminate potential dangers that could lead to serious burn injuries.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Last Frontier Eye Care is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Last Frontier Eye Care
Po Box 1049,
Nome, AK 99762-1049

Ph: (907) 443-3553
Last Frontier Eye Care
309 Bering St,
Nome, AK 99762

Ph: (907) 443-3553

News Archive

ImpactRx launches smart-phone application for physicians

ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.

Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC

Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.

Researchers reveal how cancer cells succeed at entrapping genetic program of growth inhibition

Healthy cells reduce their growth when there is a lack of oxygen (hypoxia). This makes it even more surprising that hypoxia is a characteristic feature of malignant tumours. In two publications in the current edition of the "Nature Communications" journal, researchers from Goethe University and Justus-Liebig-University of Giessen report on how cancer cells succeed at circumventing the genetic program of growth inhibition.

Transplantation of B10 cells helps inhibit development of bladder fibrosis post SCI

A team of researchers from Korea and Canada have found that transplantation of B10 cells (a stable immortalized human bone marrow derived -mesenchymal stem cell line; B10 hMSC) directly into the bladder wall of mice modeled with spinal cord injury (SCI) helped inhibit the development of bladder fibrosis and improved bladder function by promoting the growth of smooth muscle cells in the bladder.

Stony Brook Burn Center doctor offers tips on preventing burn injuries during the holiday season

It's the 'most wonderful time of the year' - but it is also one of the busiest times of year for the Suffolk County Volunteer Firefighters Burn Center at Stony Brook University Hospital. As the holidays approach, doctors at the Burn Center are urging people to take extra precautions and to eliminate potential dangers that could lead to serious burn injuries.

Read more News

› Verified 4 days ago


Optometrist in Nome, AK

Dr. Kamey Kapp, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 309 Bering Street, #1049, Nome, AK 99762
Phone: 907-443-3553    Fax: 844-901-4313
Akshay Sanjay Patil, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 1000 Greg Kruschek Avenue, Nome, AK 99762
Phone: 907-443-3311    
Tundra Health Initiative Corp
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 309 Bering St, #1049, Nome, AK 99762
Phone: 907-443-3553    Fax: 844-901-4313
Bering See Vision Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 922 E Front St, Nome, AK 99762
Phone: 469-222-8866    
Norton Sound Health Corp Eye Clinic
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1000 Greg Kruschek Ave, Nome, AK 99762
Phone: 907-443-3311    Fax: 907-443-3732
Dr. Marcy Lorraine O'neil, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 309 Bering Street, #1049, Nome, AK 99762
Phone: 907-443-3553    Fax: 844-901-4313

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.